Enabling Personalized Treatment Planning for Prostate and Bladder Cancers
At Veracyte, we are committed to advancing personalized care for urologic cancers like prostate cancer and bladder cancer. With a focus on evidence-driven science, Decipher Prostate and Decipher Bladder offer physicians and their patients actionable insights to make more informed treatment decisions, helping to improve outcomes in the cancer care journey.
Decipher is the Most Validated Tissue-based Gene Expression Test in Prostate Cancer
Learn More:
Decipher Prostate is a tissue-based genomic test that provides actionable information for treatment decision-making across the spectrum of localized prostate cancer.
Decipher Bladder is the only commercially available genomic subtyping tool for patients with bladder cancer to help inform key treatment decisions.
Learn about Veracyte
